Share of people with HIV who receive antiretroviral therapy in Chad
Chad: Share of people with HIV who receive antiretroviral therapy was 65.0% in 2024. ◆ Volatile
Share of people with HIV who receive antiretroviral therapy in Chad, 2000–2024
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
In 2024, share of people with hiv who receive antiretroviral therapy in Chad stood at 65.0%. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 12.1% on the previous year and up 132.1% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Chad peaked at 65.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Chad 93rd out of 143 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Share of people with HIV who receive antiretroviral therapy in Chad, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 1.0% | — |
| 2006 | 4.0% | +300.0% |
| 2007 | 7.0% | +75.0% |
| 2008 | 10.0% | +42.9% |
| 2009 | 13.0% | +30.0% |
| 2010 | 16.0% | +23.1% |
| 2011 | 19.0% | +18.8% |
| 2012 | 22.0% | +15.8% |
| 2013 | 25.0% | +13.6% |
| 2014 | 28.0% | +12.0% |
| 2015 | 31.0% | +10.7% |
| 2016 | 34.0% | +9.7% |
| 2017 | 37.0% | +8.8% |
| 2018 | 40.0% | +8.1% |
| 2019 | 42.0% | +5.0% |
| 2020 | 47.0% | +11.9% |
| 2021 | 51.0% | +8.5% |
| 2022 | 54.0% | +5.9% |
| 2023 | 58.0% | +7.4% |
| 2024 | 65.0% | +12.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.5% | 0.0% | 13.0% | 10 |
| 2010s | 29.4% | 16.0% | 42.0% | 10 |
| 2020s | 55.0% | 47.0% | 65.0% | 5 |
Countries ranked near Chad
More health data for Chad
- Un projection of annual infant deaths, annual growth rate -0.9964 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6578 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,071 deaths per 1,000 people (2090)
- Number of infants who die before age 1 41,435 deaths (2100)
- Total tetanus - number of reported cases, gaps filled 573 (2025)
- Total tetanus - number of reported cases, per capita 0 units per person (2025)
- Diphtheria - number of reported cases, gaps filled 4 (2025)
- Diphtheria - number of reported cases, per capita 0 units per person (2025)
- Measles - number of reported cases, gaps filled 495 (2025)
- Measles - number of reported cases, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Chad?
- Share of people with hiv who receive antiretroviral therapy in Chad was 65.0% in 2024, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Chad?
- The highest recorded value was 65.0% in 2024.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Chad?
- The lowest recorded value was 0.0% in 2000.
- How does Chad rank for share of people with hiv who receive antiretroviral therapy?
- Chad ranks 93rd out of 143 countries with data for 2024.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Chad?
- Over the last ten years it is up 132.1%. The long-run trend across the full record is volatile.
- Where does this Chad data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.